FdaApplication
ANDA 206615
Identifiers
- fda_app_no: ANDA206615
Properties
| Property | Value |
|---|---|
| applicant_name | KEY THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2017-08-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | 300MG;50MG;40MG | CAPSULE;ORAL |
1 product